{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:28:37Z","timestamp":1774657717967,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,24]]},"DOI":"10.7759\/cureus.97669","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T17:59:15Z","timestamp":1764007155000},"source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and Outcomes of the Hormone-Releasing Levonorgestrel-Intrauterine System for Adenomyosis Treatment"],"prefix":"10.7759","author":[{"given":"Vibisha","family":"Pragash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alpa","family":"Khakhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2015.09.018","article-title":"Adenomyosis: a clinical review of a challenging gynecologic condition","volume":"23","author":"Struble J","year":"2016","unstructured":"Struble J, Reid S, Bedaiwy MA. Adenomyosis: a clinical review of a challenging gynecologic condition. J Minim Invasive Gynecol. 2016, 23:164-85. 10.1016\/j.jmig.2015.09.018","journal-title":"J Minim Invasive Gynecol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2217\/whe.15.60","article-title":"Adenomyosis: what is new?","volume":"11","author":"Senturk LM","year":"2015","unstructured":"Senturk LM, Imamoglu M. Adenomyosis: what is new?. Womens Health (Lond). 2015, 11:717-24. 10.2217\/whe.15.60","journal-title":"Womens Health (Lond)"},{"key":"ref3","article-title":"Adenomyosis","author":"Gunther R","year":"2023","unstructured":"Gunther R, Walker C. Adenomyosis. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20160869","article-title":"Prevalence and burden of adenomyosis in hysterectomy specimens for benign abnormal uterine bleeding in a tertiary care institute in Pondicherry, India","volume":"4","author":"Koothan V","year":"2016","unstructured":"Koothan V, Vijay A, Maran G, Sreelakshmy. Prevalence and burden of adenomyosis in hysterectomy specimens for benign abnormal uterine bleeding in a tertiary care institute in Pondicherry, India. Int J Reprod Contracept Obstet Gynecol. 2016, 4:1119-23. 10.18203\/2320-1770.ijrcog20160869","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2016.09.006","article-title":"Adenomyosis and abnormal uterine bleeding (AUB-A)-pathogenesis, diagnosis, and management","volume":"40","author":"Abbott JA","year":"2017","unstructured":"Abbott JA. Adenomyosis and abnormal uterine bleeding (AUB-A)-pathogenesis, diagnosis, and management. Best Pract Res Clin Obstet Gynaecol. 2017, 40:68-81. 10.1016\/j.bpobgyn.2016.09.006","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2020.02.011","article-title":"The prevalence of adenomyosis in an infertile population: a cross-sectional study","volume":"40","author":"Abu Hashim H","year":"2020","unstructured":"Abu Hashim H, Elaraby S, Fouda AA, Rakhawy ME. The prevalence of adenomyosis in an infertile population: a cross-sectional study. Reprod Biomed Online. 2020, 40:842-50. 10.1016\/j.rbmo.2020.02.011","journal-title":"Reprod Biomed Online"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-016-0185-6","article-title":"Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease","volume":"14","author":"Puente JM","year":"2016","unstructured":"Puente JM, Fabris A, Patel J, Patel A, Cerrillo M, Requena A, Garcia-Velasco JA. Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease. Reprod Biol Endocrinol. 2016, 14:60. 10.1186\/s12958-016-0185-6","journal-title":"Reprod Biol Endocrinol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1718920","article-title":"Epidemiology of adenomyosis","volume":"38","author":"Upson K","year":"2020","unstructured":"Upson K, Missmer SA. Epidemiology of adenomyosis. Semin Reprod Med. 2020, 38:89-107. 10.1055\/s-0040-1718920","journal-title":"Semin Reprod Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.14337","article-title":"Prevalence of endometriosis and adenomyosis at transvaginal ultrasound examination in symptomatic women","volume":"101","author":"Orlov S","year":"2022","unstructured":"Orlov S, Jokubkiene L. Prevalence of endometriosis and adenomyosis at transvaginal ultrasound examination in symptomatic women. Acta Obstet Gynecol Scand. 2022, 101:524-31. 10.1111\/aogs.14337","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-014-3437-8","article-title":"Adenomyosis and endometriosis. Re-visiting their association and further insights into the mechanisms of auto-traumatisation. An MRI study","volume":"291","author":"Leyendecker G","year":"2015","unstructured":"Leyendecker G, Bilgicyildirim A, Inacker M, et al.. Adenomyosis and endometriosis. Re-visiting their association and further insights into the mechanisms of auto-traumatisation. An MRI study. Arch Gynecol Obstet. 2015, 291:917-32. 10.1007\/s00404-014-3437-8","journal-title":"Arch Gynecol Obstet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/0976-7800.153615","article-title":"Levonorgestrel intrauterine system (Mirena): an emerging tool for conservative treatment of abnormal uterine bleeding","volume":"6","author":"Dhamangaonkar PC","year":"2015","unstructured":"Dhamangaonkar PC, Anuradha K, Saxena A. Levonorgestrel intrauterine system (Mirena): an emerging tool for conservative treatment of abnormal uterine bleeding. J Midlife Health. 2015, 6:26-30. 10.4103\/0976-7800.153615","journal-title":"J Midlife Health"},{"key":"ref12","unstructured":"Mirena (levonorgestrel-releasing intrauterine system) package insert. (2022). Accessed. August 20, 2025: https:\/\/labeling.bayerhealthcare.com\/html\/products\/pi\/Mirena_PI.pdf."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2017.12.030","article-title":"Pathogenesis of uterine adenomyosis: invagination or metaplasia?","volume":"109","author":"Garc\u00eda-Solares J","year":"2018","unstructured":"Garc\u00eda-Solares J, Donnez J, Donnez O, Dolmans MM. Pathogenesis of uterine adenomyosis: invagination or metaplasia?. Fertil Steril. 2018, 109:371-9. 10.1016\/j.fertnstert.2017.12.030","journal-title":"Fertil Steril"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2015.05.011","article-title":"Invasion process of induced deep nodular endometriosis in an experimental baboon model: similarities with collective cell migration?","volume":"104","author":"Donnez O","year":"2015","unstructured":"Donnez O, Orellana R, Van Kerk O, Dehoux JP, Donnez J, Dolmans MM. Invasion process of induced deep nodular endometriosis in an experimental baboon model: similarities with collective cell migration?. Fertil Steril. 2015, 104:491-7.e2. 10.1016\/j.fertnstert.2015.05.011","journal-title":"Fertil Steril"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/biom13060975","article-title":"An appraisal of the tissue injury and repair (TIAR) theory on the pathogenesis of endometriosis and adenomyosis","volume":"13","author":"Habiba M","year":"2023","unstructured":"Habiba M, Benagiano G, Guo SW. An appraisal of the tissue injury and repair (TIAR) theory on the pathogenesis of endometriosis and adenomyosis. Biomolecules. 2023, 13:975. 10.3390\/biom13060975","journal-title":"Biomolecules"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/3725043","article-title":"Rare case of leiomyoma and adenomyosis in Mayer-Rokitansky-Kuster-Hauser syndrome","volume":"2016","author":"Hoo PS","year":"2016","unstructured":"Hoo PS, Norhaslinda AR, Reza JN. Rare case of leiomyoma and adenomyosis in Mayer-Rokitansky-Kuster-Hauser syndrome. Case Rep Obstet Gynecol. 2016, 2016:3725043. 10.1155\/2016\/3725043","journal-title":"Case Rep Obstet Gynecol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13708-y","article-title":"Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations","volume":"10","author":"Inoue S","year":"2019","unstructured":"Inoue S, Hirota Y, Ueno T, et al.. Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations. Nat Commun. 2019, 10:5785. 10.1038\/s41467-019-13708-y","journal-title":"Nat Commun"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201804_14807","article-title":"Linc-ROR promotes endometrial cell proliferation by activating the PI3K-Akt pathway","volume":"22","author":"Xu XY","year":"2018","unstructured":"Xu XY, Zhang J, Qi YH, Kong M, Liu SA, Hu JJ. Linc-ROR promotes endometrial cell proliferation by activating the PI3K-Akt pathway. Eur Rev Med Pharmacol Sci. 2018, 22:2218-25. 10.26355\/eurrev_201804_14807","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsrh-2023-201895","article-title":"Red blood cell capacity of modern menstrual products: considerations for assessing heavy menstrual bleeding","volume":"50","author":"DeLoughery E","year":"2024","unstructured":"DeLoughery E, Colwill AC, Edelman A, Samuelson Bannow B. Red blood cell capacity of modern menstrual products: considerations for assessing heavy menstrual bleeding. BMJ Sex Reprod Health. 2024, 50:21-6. 10.1136\/bmjsrh-2023-201895","journal-title":"BMJ Sex Reprod Health"},{"key":"ref20","unstructured":"Blood collection (guideline). (2023). Accessed. August 20, 2025: https:\/\/animal.research.uiowa.edu\/iacuc-guidelines-blood-collection."},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Radiopaedia.org. Uterus. (2025). Accessed. August 15, 2025: https:\/\/doi.org\/10.53347\/rID-25813.","DOI":"10.53347\/rID-25813"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2018.09.780","article-title":"The association of sonographic evidence of adenomyosis with severe endometriosis and gene expression in eutopic endometrium","volume":"26","author":"Dior UP","year":"2019","unstructured":"Dior UP, Nisbet D, Fung JN, et al.. The association of sonographic evidence of adenomyosis with severe endometriosis and gene expression in eutopic endometrium. J Minim Invasive Gynecol. 2019, 26:941-8. 10.1016\/j.jmig.2018.09.780","journal-title":"J Minim Invasive Gynecol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4103\/0976-7800.172299","article-title":"Histopathology findings in patients presenting with menorrhagia: a study of 100 hysterectomy specimen","volume":"6","author":"Sawke NG","year":"2015","unstructured":"Sawke NG, Sawke GK, Jain H. Histopathology findings in patients presenting with menorrhagia: a study of 100 hysterectomy specimen. J Midlife Health. 2015, 6:160-3. 10.4103\/0976-7800.172299","journal-title":"J Midlife Health"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4103\/0976-7800.133988","article-title":"Gynecological diseases in rural India: a critical appraisal of indications and route of surgery along with histopathology correlation of 922 women undergoing major gynecological surgery","volume":"5","author":"Sharma C","year":"2014","unstructured":"Sharma C, Sharma M, Raina R, Soni A, Chander B, Verma S. Gynecological diseases in rural India: a critical appraisal of indications and route of surgery along with histopathology correlation of 922 women undergoing major gynecological surgery. J Midlife Health. 2014, 5:55-61. 10.4103\/0976-7800.133988","journal-title":"J Midlife Health"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.01.016","article-title":"Adenomyosis incidence, prevalence and treatment: United States population-based study 2006-2015","volume":"223","author":"Yu O","year":"2020","unstructured":"Yu O, Schulze-Rath R, Grafton J, Hansen K, Scholes D, Reed SD. Adenomyosis incidence, prevalence and treatment: United States population-based study 2006-2015. Am J Obstet Gynecol. 2020, 223:94.e1-10. 10.1016\/j.ajog.2020.01.016","journal-title":"Am J Obstet Gynecol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2008.11.004","article-title":"The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis","volume":"79","author":"Sheng J","year":"2009","unstructured":"Sheng J, Zhang WY, Zhang JP, Lu D. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis. Contraception. 2009, 79:189-93. 10.1016\/j.contraception.2008.11.004","journal-title":"Contraception"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2015.05.015","article-title":"Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial","volume":"92","author":"Shaaban OM","year":"2015","unstructured":"Shaaban OM, Ali MK, Sabra AM, Abd El Aal DE. Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial. Contraception. 2015, 92:301-7. 10.1016\/j.contraception.2015.05.015","journal-title":"Contraception"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4103\/0976-7800.109633","article-title":"Are women satisfied when using levonorgestrel-releasing intrauterine system for treatment of abnormal uterine bleeding?","volume":"4","author":"Mansukhani N","year":"2013","unstructured":"Mansukhani N, Unni J, Dua M, Darbari R, Malik S, Verma S, Bathla S. Are women satisfied when using levonorgestrel-releasing intrauterine system for treatment of abnormal uterine bleeding?. J Midlife Health. 2013, 4:31-5. 10.4103\/0976-7800.109633","journal-title":"J Midlife Health"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjog.2017.12.036","article-title":"Postoperative maintenance levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyoma","volume":"57","author":"Lin CJ","year":"2018","unstructured":"Lin CJ, Hsu TF, Chang YH, Huang BS, Jiang LY, Wang PH, Chen YJ. Postoperative maintenance levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyoma. Taiwan J Obstet Gynecol. 2018, 57:47-51. 10.1016\/j.tjog.2017.12.036","journal-title":"Taiwan J Obstet Gynecol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2012.743017","article-title":"Improvement in chronic pelvic pain after gonadotropin releasing hormone analogue (GnRH-a) administration in premenopausal women suffering from adenomyosis or endometriosis: a retrospective study","volume":"29","author":"Morelli M","year":"2013","unstructured":"Morelli M, Rocca ML, Venturella R, Mocciaro R, Zullo F. Improvement in chronic pelvic pain after gonadotropin releasing hormone analogue (GnRH-a) administration in premenopausal women suffering from adenomyosis or endometriosis: a retrospective study. Gynecol Endocrinol. 2013, 29:305-8. 10.3109\/09513590.2012.743017","journal-title":"Gynecol Endocrinol"},{"key":"ref31","unstructured":"National Institute for Health and Care Excellence guideline [NG88]. Heavy menstrual bleeding. assessment and management. (2008). Accessed: August 20, 2025: https:\/\/www.nice.org.uk\/guidance\/ng88."},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogc.2018.03.007","article-title":"No. 292-abnormal uterine bleeding in pre-menopausal women","volume":"40","author":"Singh S","year":"2018","unstructured":"Singh S, Best C, Dunn S, Leyland N, Wolfman WL. No. 292-abnormal uterine bleeding in pre-menopausal women. J Obstet Gynaecol Can. 2018, 40:e391-415. 10.1016\/j.jogc.2018.03.007","journal-title":"J Obstet Gynaecol Can"},{"key":"ref33","unstructured":"Skyla (levonorgestrel-releasing intrauterine system) package insert. Whippany, NJ. Bayer HealthCare Pharmaceuticals Inc.. (2023). Accessed: August 20, 2025: https:\/\/labeling.bayerhealthcare.com\/html\/products\/pi\/Skyla_PI.pdf."},{"key":"ref34","unstructured":"Liletta (levonorgestrel-releasing intrauterine system) package insert. Irvine, CA. Allergan USA, Inc.. (2023). Accessed: August 20, 2025: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/206229s008lbl.pdf."},{"key":"ref35","unstructured":"Kyleena (levonorgestrel-releasing intrauterine system) package insert. Whippany, NJ. Bayer HealthCare Pharmaceuticals Inc.. (2023). Accessed: August 20, 2025: https:\/\/labeling.bayerhealthcare.com\/html\/products\/pi\/Kyleena_PI.pdf."},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2010.10.009","article-title":"Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis","volume":"95","author":"Ozdegirmenci O","year":"2011","unstructured":"Ozdegirmenci O, Kayikcioglu F, Akgul MA, Kaplan M, Karcaaltincaba M, Haberal A, Akyol M. Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis. Fertil Steril. 2011, 95:497-502. 10.1016\/j.fertnstert.2010.10.009","journal-title":"Fertil Steril"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/jog.13189","article-title":"Sonographic evaluation of uterine volume and its clinical importance","volume":"43","author":"Sheth SS","year":"2017","unstructured":"Sheth SS, Hajari AR, Lulla CP, Kshirsagar D. Sonographic evaluation of uterine volume and its clinical importance. J Obstet Gynaecol Res. 2017, 43:185-9. 10.1111\/jog.13189","journal-title":"J Obstet Gynaecol Res"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3892\/br.2024.1797","article-title":"Efficacy of hysteroscopic levonorgestrel\u2011releasing intrauterine device fixation in the treatment of adenomyosis: a cohort study","volume":"21","author":"Xu P","year":"2024","unstructured":"Xu P, Ling S, Hu E, Ma L, Liu J, Yi B. Efficacy of hysteroscopic levonorgestrel\u2011releasing intrauterine device fixation in the treatment of adenomyosis: a cohort study. Biomed Rep. 2024, 21:109. 10.3892\/br.2024.1797","journal-title":"Biomed Rep"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2023.10.012","article-title":"Feasibility and effectiveness of hysteroscopic suture fixation of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis","volume":"31","author":"Lv N","year":"2024","unstructured":"Lv N, Guo J, Yuan Q, Shen S, Chen Q, Tong J. Feasibility and effectiveness of hysteroscopic suture fixation of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis. J Minim Invasive Gynecol. 2024, 31:57-63. 10.1016\/j.jmig.2023.10.012","journal-title":"J Minim Invasive Gynecol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2023.108772","article-title":"The suture fixation of levonorgestrel-releasing intrauterine device in the treatment of adenomyosis: a case report","volume":"110","author":"Cui H","year":"2023","unstructured":"Cui H, Huang J. The suture fixation of levonorgestrel-releasing intrauterine device in the treatment of adenomyosis: a case report. Int J Surg Case Rep. 2023, 110:108772. 10.1016\/j.ijscr.2023.108772","journal-title":"Int J Surg Case Rep"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.52054\/FVVO.15.4.107","article-title":"Suture-fixation of a levonorgestrel-releasing intrauterine device under hysteroscopic guidance","volume":"15","author":"Paul PG","year":"2023","unstructured":"Paul PG, Shah M, Sridivya Chowdary V, Anusha Raaj A, Paul G. Suture-fixation of a levonorgestrel-releasing intrauterine device under hysteroscopic guidance. Facts Views Vis Obgyn. 2023, 15:355-8. 10.52054\/FVVO.15.4.107","journal-title":"Facts Views Vis Obgyn"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2019.03.101","article-title":"Effect of pretreatment with a levonorgestrel-releasing intrauterine system on IVF and vitrified-warmed embryo transfer outcomes in women with adenomyosis","volume":"39","author":"Liang Z","year":"2019","unstructured":"Liang Z, Yin M, Ma M, Wang Y, Kuang Y. Effect of pretreatment with a levonorgestrel-releasing intrauterine system on IVF and vitrified-warmed embryo transfer outcomes in women with adenomyosis. Reprod Biomed Online. 2019, 39:111-8. 10.1016\/j.rbmo.2019.03.101","journal-title":"Reprod Biomed Online"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/410310-efficacy-and-outcomes-of-the-hormone-releasing-levonorgestrel-intrauterine-system-for-adenomyosis-treatment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T17:59:27Z","timestamp":1764007167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/410310-efficacy-and-outcomes-of-the-hormone-releasing-levonorgestrel-intrauterine-system-for-adenomyosis-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":42,"URL":"https:\/\/doi.org\/10.7759\/cureus.97669","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,24]]}}}